Stock listing

NASDAQ:EOLS Evolus, Inc. Common Stock Stock

Home listing (NASDAQ) of Evolus, Inc. Common Stock

Follow Evolus, Inc. Common Stock into a list and get an email when it puts out news.

Share price · NASDAQ:EOLS

$6.52 USD -0.55 (-7.8%)

Close on Nov 20, 2026

Past year -1.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.50 – $7.19 USDNov 20, 2026
Volume
813,646 sharesNov 20, 2026
Market cap
$431.5M USDAt the close on Nov 20, 2026 · price × 66.19M shares outstanding
52-week range
$3.86 – $9.31 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7.07M USDMedian day 734,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Evolus, Inc. Common Stock logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:EOLS · Home$6.52 USD-0.55 (-7.8%)813,646$6.79$7.19$6.50$7.07Close on Nov 20, 2026
Frankfurt:EVL€6.284 EUR-0.182 (-2.8%)—€6.284€6.284€6.284€6.466Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:EOLS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.52-0.55-7.8%$6.79$7.19$6.50813,646
$7.07+0.38+5.7%$6.68$7.09$6.63802,520
$6.69+0.06+0.9%$6.61$6.72$6.30670,639
$6.63-0.33-4.7%$6.90$7.03$6.615641,076
$6.96-0.22-3.1%$7.18$7.18$6.85455,367
$7.18-0.24-3.2%$7.38$7.65$7.15737,047
$7.42+0.61+9.0%$6.86$7.44$6.851,287,320
$6.81-0.17-2.4%$6.97$6.99$6.6355,816,220
$6.98+0.175+2.6%$6.88$7.04$6.721,150,207
$6.805+0.01+0.1%$6.74$6.92$6.571,521,611
$6.795-0.675-9.0%$6.64$7.27$6.4122,128,693
$7.47+0.10+1.4%$7.51$7.65$7.33749,559
$7.37+0.21+2.9%$7.17$7.415$7.17440,561
$7.16-0.19-2.6%$7.34$7.44$7.15712,590
$7.35-0.17-2.3%$7.48$7.56$7.24793,582
$7.52-0.115-1.5%$7.75$7.83$7.38789,229
$7.635+0.265+3.6%$7.38$7.705$7.30671,393
$7.37+0.20+2.8%$7.18$7.37$7.07600,999
$7.17+0.16+2.3%$7.06$7.19$6.90430,106
$7.01-0.40-5.4%$7.31$7.31$6.93597,823
$7.41+0.01+0.1%$7.39$7.625$7.30621,862
$7.40+0.03+0.4%$7.37$7.43$7.27912,577
$7.37+0.01+0.1%$7.38$7.63$7.335447,832
$7.36+0.26+3.7%$7.10$7.37$7.10517,872
$7.10-0.47-6.2%$7.61$7.61$7.015761,700
$7.57+0.35+4.8%$7.26$7.71$7.22901,500
$7.22-0.29-3.9%$7.42$7.60$7.2051,007,600
$7.51-0.24-3.1%$7.68$7.70$7.48654,400
$7.75+0.02+0.3%$7.76$7.83$7.671,002,200
$7.73-0.07-0.9%$7.77$7.829$7.61430,100
$7.80+0.06+0.8%$7.68$7.805$7.5351,078,000
$7.74+0.36+4.9%$7.37$7.75$7.333595,100
$7.38-0.09-1.2%$7.47$7.56$7.16663,900
$7.47+0.33+4.6%$7.07$7.52$7.07786,400
$7.14-0.55-7.2%$7.72$7.72$6.9132,070,900
$7.69-0.31-3.9%$7.89$8.01$7.69922,600
$8.00+0.01+0.1%$7.97$8.15$7.87624,400
$7.99+0.03+0.4%$7.91$8.11$7.83415,100
$7.96-0.01-0.1%$7.90$8.075$7.805478,200
$7.97+0.11+1.4%$7.84$8.00$7.712398,300
$7.86-0.14-1.7%$7.96$8.00$7.79363,000
$8.00-0.25-3.0%$8.33$8.51$7.88415,900
$8.25+0.26+3.3%$8.10$8.265$8.00500,700
$7.99+0.13+1.7%$7.93$7.995$7.76420,700
$7.86-0.15-1.9%$8.00$8.00$7.8051,181,600
$8.01+0.02+0.3%$8.05$8.14$7.771,225,200
$7.99+0.08+1.0%$7.93$8.09$7.82683,400
$7.91-0.02-0.3%$7.88$7.95$7.59637,900
$7.93+0.09+1.1%$7.90$8.25$7.87515,600
$7.84-0.07-0.9%$8.01$8.15$7.81586,500
$7.91-0.66-7.7%$8.43$8.45$7.751,211,700
$8.57-0.31-3.5%$8.85$9.05$8.51996,600
$8.88-0.42-4.5%$9.00$9.12$8.7511,727,700
$9.30+0.25+2.8%$9.05$9.31$8.975696,400
$9.05-0.01-0.1%$9.08$9.10$8.91734,200
$9.06-0.02-0.2%$9.04$9.13$8.93773,500
$9.08-0.01-0.1%$9.04$9.124$8.93594,000
$9.09+0.21+2.4%$8.85$9.15$8.751,025,200
$8.880.000.0%$8.84$8.94$8.5951,059,300
$8.88+0.10+1.1%$8.78$9.035$8.601,194,800
$8.78-0.195-2.2%$8.86$9.08$8.771,512,800
$8.975+0.195+2.2%$8.72$9.12$8.701,796,100
$8.78+0.39+4.6%$8.39$8.82$8.261,320,200
$8.39+0.04+0.5%$8.35$8.48$8.235582,700
$8.35-0.25-2.9%$8.55$8.55$8.32663,000
Ticker
NASDAQ:EOLS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Evolus, Inc. Common Stock news

Evolus, Inc. Common Stock on 6ix

News releases
21 in the last 12 months · 145 in all · newest Nov 13, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Aug 5, 2026
Decks
17 decks · latest Nov 4, 2026

Where Evolus, Inc. Common Stock is listed

ListingExchangeCountryCurrency
NASDAQ:EOLS · Home listing · This pageNASDAQUnited StatesUSD
gettex:EVLgettexGermanyEUR
Frankfurt:EVLFrankfurtGermanyEUR
LS Exchange:A2JDYXLS ExchangeGermanyEUR
Lang & Schwarz:A2JDYXLang & SchwarzGermanyEUR
BOATS:EOLSBOATSUnited StatesUSD
Tradegate:EVLTradegateGermanyEUR
Dusseldorf:EVLDusseldorfGermanyEUR
LSE:0K16LSEUnited KingdomUSD
Munich:EVLMunichGermanyEUR
Stuttgart:EVLStuttgartGermanyEUR

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$546.7M USD
P/E
Loss
EV/sales
1.7×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
66.4%
Operating margin
−4.8%
Net margin
−9.6%
Debt to equity
Negative equity
Beta vs S&P 500
1.34

Forecasts

4 strong buy · 1 buy · 1 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
15.40 USD · Analysts' mean
EPS, year to Dec 2026
-0.033 · 4 analysts
Revenue, year to Dec 2026
334.3M · 6 analysts

Team and board

Officers

OfficerRole
David MoatazediPresident and Chief Executive Officer
Tatjana MitchellChief Financial Officer
Jeff PlumerGeneral Counsel
Nareg SagherianVice President, Head of Global Investor Relations and Corporate Communications
Jon YerburySenior Vice President, Operations
Kourtney CavallioSenior Vice President, Marketing
Kurt KnabSenior Vice President, Sales
Peter KreymermanEvolus VP & Head of Global Medical Affairs, Assistant Professor of Plastic Surgery at Campbell University
Umberto La MagnaSenior Vice President, Evolus International
Donna Lynne ColonnaDirector of Medical Affairs, RN, BSN, Certified Nurse Injector, Certified Plastic Surgery Nurse
Jessica NovakChief People Officer
Meha PatelDirector of Medical Affairs, PA-C, MSPAS
Monica ChampaneriaEvolus Medical Affairs Operations & Event Manager
Rui AvelarChief Medical Officer and Head of Research and Development

Board

DirectorRole
David MoatazediPresident and Chief Executive Officer
Kourtney CavallioSenior Vice President, Marketing
Rui AvelarChief Medical Officer and Head of Research and Development
Tatjana MitchellChief Financial Officer
Umberto La MagnaSenior Vice President, Evolus International

Events

Calls

CallWhenStatus
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2026 Earnings CallWed, Aug 05, 2026 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2026 Earnings CallMon, May 04, 2026 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2025 Earnings CallTue, Mar 03, 2026 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q3 2025 Earnings CallWed, Nov 05, 2025 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2025 Earnings CallTue, Aug 05, 2025 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2025 Earnings CallWed, May 07, 2025 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2024 Earnings CallTue, Mar 04, 2025 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q3 2024 Earnings CallWed, Nov 06, 2024 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2024 Earnings CallWed, Jul 31, 2024 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2024 Earnings CallTue, May 07, 2024 · 4:30 PM ETReplay
All 22 calls
CallWhenStatus
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2023 Earnings CallThu, Mar 07, 2024 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q3 2023 Earnings CallTue, Nov 07, 2023 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2023 Earnings CallWed, Aug 02, 2023 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2023 Earnings CallTue, May 09, 2023 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2022 Earnings CallWed, Mar 08, 2023 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q3 2022 Earnings CallTue, Nov 08, 2022 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2022 Earnings CallTue, Aug 02, 2022 · 9:00 AM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2022 Earnings CallTue, May 10, 2022 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q4 2021 Earnings CallThu, Mar 03, 2022 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q3 2021 Earnings CallTue, Nov 02, 2021 · 9:00 AM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q2 2021 Earnings CallWed, Aug 04, 2021 · 4:30 PM ETReplay
Evolus, Inc. Common Stock (NASDAQ:EOLS) Q1 2021 Earnings CallWed, May 12, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close−9.0%
Q2 2026Aug 5, 2026 · After close+19.9%
Q1 2026May 4, 2026 · After close+14.2%
Q4 2025Mar 3, 2026+30.3%
Q3 2025Nov 5, 2025 · After close+5.4%
Q2 2025Aug 5, 2025 · After close−28.5%
Q1 2025May 7, 2025 · After close−14.2%
Q4 2024Mar 4, 2025 · After close−1.3%
Q3 2024Nov 6, 2024 · After close−15.0%
Q2 2024Jul 31, 2024 · After close+13.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close−1.2%
Q4 2023Mar 7, 2024 · After close−4.9%
Q3 2023Nov 7, 2023 · After close+8.2%
Q2 2023Aug 2, 2023 · After close+2.1%
Q1 2023May 9, 2023 · After close+16.0%
Q4 2022Mar 8, 2023 · After close−3.2%
Q3 2022Nov 8, 2022 · After close−9.1%
Q2 2022Aug 2, 2022 · Before open−17.6%
Q1 2022May 10, 2022 · After close+7.7%
Q4 2021Mar 3, 2022 · After close+5.7%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings39 slidesNov 4, 2026
Q2 2026 Earnings PresentationEarnings38 slidesAug 5, 2026
Q1 2026 Earnings PresentationEarnings36 slidesMay 4, 2026
Q4 2025 Earnings PresentationEarnings36 slidesMar 3, 2026
Q3 2025 Earnings PresentationEarnings36 slidesNov 5, 2025
Q4 2024 Earnings PresentationEarnings37 slidesMar 4, 2025
Q3 2024 Earnings PresentationEarnings37 slidesNov 6, 2024
Investor Day (September 2024)Investor day145 slidesSep 12, 2024
Q2 2024 Earnings PresentationEarnings34 slidesJul 31, 2024
Q1 2024 Earnings PresentationEarnings34 slidesMay 7, 2024
All 17 decks
DeckKindSlidesDate
Q4 2023 Earnings PresentationEarnings10 slidesMar 7, 2024
Q3 2023 Earnings PresentationEarnings19 slidesNov 7, 2023
Q2 2023 Earnings PresentationEarnings37 slidesAug 2, 2023
Technical Presentation (January 2023)Technical23 slidesJan 30, 2023
Investor Presentation (January 2020)Investor deck20 slidesJan 10, 2020
Investor Day (May 2019)Investor day64 slidesMay 8, 2019
Investor Presentation (January 2019)Investor deck21 slidesJan 4, 2019

Open Decks

IPO

Priced at US$12.00 a share on Feb 7, 2018.

Price
US$12.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$60 million
Underwriters' option
Up to 750,000 more shares
Listing
EOLS on the Nasdaq Global Market
Underwriters
Cantor, Mizuho Securities, SunTrust Robinson Humphrey, JMP Securities · In the order on the cover
Shares delivered
On or about Feb 12, 2018

Steps

StepWhen
Draft sent to the SEC in confidenceAug 28, 2017
Filed publiclyJan 9, 2018
Amended 3 timesNewest Feb 1, 2018
Shares registered with an exchangeFeb 1, 2018
Declared effective by the SECFeb 7, 2018
Final prospectus, with the priceFeb 9, 2018

Open IPO · From the cover of the final prospectus (424B4) filed Feb 9, 2018

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue297.2M266.3M202.1M148.6M99.7M56.5M34.9M000
Cost of revenue100.1M84.0M64.5M58.8M43.5M18.3M8.01M0218.0K326.0K
Gross profit197.1M182.3M137.6M89.8M56.1M38.2M26.9M0-218.0K-326.0K
Research and development9.58M9.17M6.56M4.74M2.06M1.72M3.97M6.49M6.69M12.6M
Selling, general and administrative220.8M198.0M164.9M141.8M112.1M98.2M113.6M29.1M4.82M7.03M
Operating income-32.7M-34.4M-49.2M-65.3M-44.4M-153.1M-98.9M-46.1M-11.7M-20.0M
Depreciation and amortization7.51M5.30M5.13M3.72M5.62M7.03M4.13M9.00K218.0K326.0K
EBITDA-25.2M-29.1M-44.1M-61.6M-38.8M-146.0M-94.8M-46.1M-11.5M-19.6M
Interest expense19.7M18.7M13.8M9.10M1.40M10.5M7.95M863.0K5.00K0
Income before tax-51.0M-49.8M-61.5M-74.3M-46.8M-162.9M-105.1M-46.8M-11.7M-20.0M
Income tax677.0K664.0K176.0K95.0K42.0K77.0K-15.0M65.0K-7.25M93.0K
Net income-51.6M-50.4M-61.7M-74.4M-46.8M-163.0M-90.0M-46.9M-4.48M-20.1M
Earnings per share, basic-0.80-0.81-1.08-1.33-0.94-4.83-3.19-1.92-0.27-1.08
Earnings per share, diluted-0.80-0.81-1.08-1.33-0.94-4.83-3.19-1.92-0.27

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents53.8M87.0M62.8M53.9M146.3M102.6M109.9M93.2M0187.0K
Short-term investments05.00M19.9M0187.0K
Receivables54.7M47.7M30.5M22.4M14.7M9.68M10.7M072.6M
Inventory27.0M12.2M11.0M18.9M1.76M3.35M6.41M0
Current assets142.9M151.3M112.4M100.8M178.8M127.6M152.2M94.3M72.8M211.0K
Property, plant and equipment5.37M3.22M2.09M2.62M1.37M1.30M902.0K00
Goodwill21.2M21.2M21.2M21.2M21.2M21.2M21.2M21.2M21.2M21.2M
Total assets225.9M232.6M189.0M178.0M257.5M209.1M240.4M171.8M152.2M77.5M
Accounts payable23.4M9.24M4.27M8.94M6.09M9.62M5.80M1.56M445.0K2.88M
Current liabilities75.3M63.0M48.3M46.5M57.7M180.2M24.4M5.28M212.7M63.3M
Long-term debt146.1M121.5M120.4M71.9M71.2M40.5M73.5M0
Total debt146.1M121.5M120.4M71.9M71.2M138.3M73.5M0211.3M59.8M
Total liabilities249.0M227.0M209.7M159.5M175.6M282.0M161.0M87.5M227.8M84.6M
Shareholders' equity-23.1M5.52M-20.7M18.5M81.9M-73.0M79.5M84.4M-75.5M-7.11M
Shares outstanding65.0M63.5M57.8M56.3M55.6M33.7M33.6M27.3M16.5M18.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-42.3M-18.0M-34.0M-84.9M-33.4M-57.9M-93.4M-25.7M-13.2M-13.3M
Capital spending-3.44M-1.47M-473.0K-1.62M-393.0K-815.0K-345.0K-9.00K0-9.00K
Free cash flow-45.7M-19.5M-34.5M-86.5M-33.8M-58.7M-93.7M-25.7M-13.2M-13.3M
Cash from investing-8.45M-4.82M-1.63M-2.94M4.03M12.2M-23.4M-9.00K0-9.00K
Cash from financing17.3M47.4M44.6M-4.15M73.1M38.3M133.5M118.8M13.0M13.3M
Share buybacks103.1M73.1M-239.0K-1.29M-1.29M
Change in cash-33.1M24.1M8.92M-92.3M43.7M-7.33M16.7M93.2M-187.0K-187.0K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 9, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeAug 31, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026ResultsSEC
8-K · Current reportAug 4, 2026Material contractSEC
8-K · Current reportJul 8, 2026Material contractSEC
Show 200 filings
FilingDateTypeFiled with
EFFECT · Notice that a registration is effectiveJun 15, 2026Other filingsSEC
8-K · Current reportJun 12, 2026Meeting outcomeSEC
CORRESP · Letter to the SECJun 10, 2026Other filingsSEC
UPLOAD · Letter from the SECJun 10, 2026Other filingsSEC
S-3 · Registration statementJun 5, 2026Offer documentSEC
10-Q · Quarterly reportMay 4, 2026Quarterly reportSEC
8-K · Current reportMay 4, 2026ResultsSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
8-K · Current reportMar 13, 2026Management or board changeSEC
S-8 · Registration statement for employee plansMar 3, 2026Offer documentSEC
10-K · Annual reportMar 3, 2026Annual reportSEC
8-K · Current reportMar 3, 2026ResultsSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
8-K · Current reportJan 9, 2026ResultsSEC
4 · Change in ownershipDec 29, 2025Insider tradeSEC
4 · Change in ownershipDec 29, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 9, 2025Insider tradeSEC
8-K · Current reportSep 8, 2025Management or board changeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 18, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 5, 2025ResultsSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
144 · Notice of proposed saleJun 16, 2025Other filingsSEC
144 · Notice of proposed saleJun 13, 2025Other filingsSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
8-K · Current reportJun 6, 2025Management or board changeSEC
8-K · Current reportMay 27, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
10-Q · Quarterly reportMay 7, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
8-K · Current reportMay 5, 2025Material contractSEC
DEFA14A · Additional proxy materialApr 25, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
ARS · Annual report to shareholdersApr 25, 2025Annual reportSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 20, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
144 · Notice of proposed saleMar 12, 2025Other filingsSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMar 4, 2025Offer documentSEC
10-K · Annual reportMar 4, 2025Annual reportSEC
8-K · Current reportMar 4, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2025Big-stake noticeSEC
8-K · Current reportJan 21, 2025ResultsSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
UPLOAD · Letter from the SECDec 18, 2024Other filingsSEC
CORRESP · Letter to the SECDec 12, 2024Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECNov 14, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansNov 6, 2024Offer documentSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024ResultsSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
10-Q · Quarterly reportJul 31, 2024Quarterly reportSEC
8-K · Current reportJul 31, 2024ResultsSEC
4 · Change in ownershipJul 3, 2024Insider tradeSEC
3 · Initial statement of ownershipJul 3, 2024Insider tradeSEC
8-K · Current reportJul 1, 2024Management or board changeSEC
8-K · Current reportJun 11, 2024Management or board changeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
144 · Notice of proposed saleJun 6, 2024Other filingsSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
144 · Notice of proposed saleJun 5, 2024Other filingsSEC
144 · Notice of proposed saleJun 4, 2024Other filingsSEC
144 · Notice of proposed saleJun 3, 2024Other filingsSEC
4 · Change in ownershipMay 15, 2024Insider tradeSEC
4 · Change in ownershipMay 15, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
144 · Notice of proposed saleMay 14, 2024Other filingsSEC
144 · Notice of proposed saleMay 13, 2024Other filingsSEC
10-Q · Quarterly reportMay 7, 2024Quarterly reportSEC
8-K · Current reportMay 7, 2024ResultsSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
8-K · Current reportApr 3, 2024Management or board changeSEC
4 · Change in ownershipMar 29, 2024Insider tradeSEC
4 · Change in ownershipMar 21, 2024Insider tradeSEC
4 · Change in ownershipMar 21, 2024Insider tradeSEC
4 · Change in ownershipMar 21, 2024Insider tradeSEC
8-K · Current reportMar 13, 2024Material contractSEC
424B5 · ProspectusMar 11, 2024Offer documentSEC
S-8 · Registration statement for employee plansMar 7, 2024Offer documentSEC
10-K · Annual reportMar 7, 2024Annual reportSEC
8-K · Current reportMar 7, 2024ResultsSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 12, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 9, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
144 · Notice of proposed saleJan 30, 2024Other filingsSEC
SC 13G · Big-stake noticeJan 29, 2024Big-stake noticeSEC
8-K · Current reportJan 16, 2024ResultsSEC
8-K · Current reportDec 20, 2023Material contractSEC
4 · Change in ownershipDec 8, 2023Insider tradeSEC
144 · Notice of proposed saleDec 6, 2023Other filingsSEC
SC 13G · Big-stake noticeNov 27, 2023Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2023Quarterly reportSEC
8-K · Current reportNov 7, 2023ResultsSEC
4 · Change in ownershipOct 18, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 18, 2023Big-stake noticeSEC
S-8 · Registration statement for employee plansOct 6, 2023Offer documentSEC
SC 13G/A · Big-stake notice, amendedOct 4, 2023Big-stake noticeSEC
4 · Change in ownershipSep 8, 2023Insider tradeSEC
4 · Change in ownershipAug 23, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 23, 2023Insider tradeSEC
4 · Change in ownershipAug 16, 2023Insider tradeSEC
4 · Change in ownershipAug 16, 2023Insider tradeSEC
4 · Change in ownershipAug 16, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedAug 14, 2023Big-stake noticeSEC
10-Q · Quarterly reportAug 2, 2023Quarterly reportSEC
8-K · Current reportAug 2, 2023ResultsSEC
8-K · Current reportJul 27, 2023ResultsSEC
SC 13G · Big-stake noticeJun 16, 2023Big-stake noticeSEC
8-K · Current reportJun 14, 2023Meeting outcomeSEC
424B5 · ProspectusJun 9, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 9, 2023Other filingsSEC
CORRESP · Letter to the SECJun 7, 2023Other filingsSEC
S-3/A · Registration statement, amendedJun 7, 2023Offer documentSEC

This page holds 200 of 558 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Evolus, Inc. Common Stock’s releases · as of Oct 30, 2026

Common shares
66,188,366
Fully diluted
66,382,701

Fully diluted

LineSharesAs of
Common shares66,188,366Oct 30, 2026
Options and RSUs194,335

Warrants and options

Lot
RSUs · expiry not stated

Share count over time

CountShares
Oct 30, 202666,188,366

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Nantahala Capital Management, LLC6.24M9.4%US$50MSep 30, 2026
BlackRock5.32M8.0%US$42.5MSep 30, 2026
Soleus Capital Management, L.P.5.09M7.7%US$40.7MSep 30, 2026
Vanguard3.36M5.1%US$26.9MSep 30, 2026
Braidwell LP3.08M4.7%US$24.7MSep 30, 2026
Frazier Life Sciences Management, L.P.2.63M4.0%US$21MSep 30, 2026
Perceptive Advisors LLC2.46M3.7%US$19.7MSep 30, 2026
State Street1.85M2.8%US$14.8MSep 30, 2026
Millennium1.65M2.5%US$13.2MSep 30, 2026
Geode Capital1.58M2.4%US$12.6MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Pinnacle Associates LTD1.57M2.4%US$12.6MSep 30, 2026
Armistice Capital, LLC1.44M2.2%US$11.5MSep 30, 2026
Goldman Sachs1.25M1.9%US$10MSep 30, 2026
Rice Hall James & Associates, LLC1.2M1.8%US$9.62MSep 30, 2026
Stonepine Capital Management, LLC972K1.5%US$7.77MSep 30, 2026
Renaissance Technologies711K1.1%US$5.68MSep 30, 2026
Assenagon Asset Management S.A.652K0.98%US$5.21MSep 30, 2026
AWH Capital, L.P.625K0.94%US$5MSep 30, 2026
UBS540K0.82%US$4.32MSep 30, 2026
Schwab529K0.80%US$4.23MSep 30, 2026
Northern Trust480K0.73%US$3.84MSep 30, 2026
Soviero Asset Management, LP470K0.71%US$3.76MSep 30, 2026
DWS448K0.68%US$3.58MSep 30, 2026
Stifel Financial Corp417K0.63%US$3.34MSep 30, 2026
CM Management, LLC380K0.57%US$3.04MSep 30, 2026
D. E. Shaw & Co., Inc.339K0.51%US$2.71MSep 30, 2026
Barclays288K0.43%US$2.3MSep 30, 2026
Squarepoint Ops LLC248K0.37%US$1.98MSep 30, 2026
Wellington210K0.32%US$1.68MSep 30, 2026
Quantinno Capital Management LP207K0.31%US$1.66MSep 30, 2026
Morgan Stanley190K0.29%US$1.52MSep 30, 2026
Prudential Financial Inc184K0.28%US$1.47MSep 30, 2026
Two Sigma173K0.26%US$1.38MSep 30, 2026
BNY166K0.25%US$1.33MSep 30, 2026
Angeles Wealth Management, LLC158K0.24%US$1.26MSep 30, 2026
KVP Capital Advisors, LP150K0.23%US$1.2MSep 30, 2026
Jacobs Levy Equity Management, Inc149K0.22%US$1.19MSep 30, 2026
Potomac Capital Management, Inc.142K0.21%US$1.13MSep 30, 2026
Panagora Asset Management Inc139K0.21%US$1.11MSep 30, 2026
T. Rowe Price138K0.21%US$1.1MSep 30, 2026
Nuveen130K0.20%US$1.04MSep 30, 2026
AQR Capital Management LLC127K0.19%US$1.02MSep 30, 2026
Bank of America124K0.19%US$990KSep 30, 2026
Russell Investments Group, Ltd.119K0.18%US$953KSep 30, 2026
National Philanthropic Trust117K0.18%US$934KSep 30, 2026
ADAR1 Capital Management, LLC100K0.15%US$800KSep 30, 2026
State Of Wisconsin Investment Board92,2680.14%US$738KSep 30, 2026
LPL Financial LLC87,8490.13%US$703KSep 30, 2026
Profund Advisors LLC70,7110.11%US$566KSep 30, 2026
Susquehanna70,4660.11%US$564KSep 30, 2026

This page holds 50 of 166 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.54M2.3%US$10.7MJun 30, 2026
iShares Russell 2000 ETF1.54M2.3%US$10.7MJun 30, 2026
Vanguard Extended Market Index Fund770K1.2%US$5.35MJun 30, 2026
Fidelity Small Cap Index Fund646K0.98%US$3.77MJul 31, 2026
iShares Russell 2000 Growth ETF558K0.84%US$3.87MJun 30, 2026
Fidelity Extended Market Index Fund338K0.51%US$2.22MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF325K0.49%US$2.26MJun 30, 2026
Schwab U.S. Small-Cap ETF309K0.47%US$2.03MMay 31, 2026
Vanguard Russell 2000 Index Fund288K0.43%US$1.89MMay 31, 2026
iShares Micro-Cap ETF199K0.30%US$1.38MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares U.S. Pharmaceuticals ETF172K0.26%US$1.19MJun 30, 2026
Schwab Small-Cap Index Fund144K0.22%US$843KJul 31, 2026
Vanguard Health Care Index Fund143K0.22%US$940KMay 31, 2026
Clearwater Select Equity Fund116K0.17%US$803KJun 30, 2026
Fidelity Total Market Index Fund114K0.17%US$747KMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account107K0.16%US$745KJun 30, 2026
Master Small Cap Index Series104K0.16%US$721KJun 30, 2026
Fidelity Series Total Market Index Fund97,7360.15%US$641KMay 31, 2026
Nuveen Small Cap Blend Index Fund79,2300.12%US$463KJul 31, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF72,8750.11%US$478KMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF72,1690.11%US$501KJun 30, 2026
EQ/2000 Managed Volatility Portfolio64,1550.10%US$445KJun 30, 2026
Tax-Managed U.S. Mid & Small Cap Fund60,8840.09%US$356KJul 31, 2026
Fidelity Small Cap Growth Index Fund55,6450.08%US$386KJun 30, 2026
Vanguard Russell 2000 Growth Index Fund52,2260.08%US$343KMay 31, 2026
Schwab U.S. Broad Market ETF45,9760.07%US$302KMay 31, 2026
Fullerthaler Behavioral Micro-Cap Equity Fund40,0500.06%US$278KJun 30, 2026
Fidelity Nasdaq Composite Index Fund37,1580.06%US$244KMay 31, 2026
Fidelity ZERO Total Market Index Fund35,3110.05%US$206KJul 31, 2026
LVIP State Street Small-Cap Index Fund35,0000.05%US$243KJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund33,5590.05%US$233KJun 30, 2026
EQ/Small Company Index Portfolio33,1000.05%US$230KJun 30, 2026
EQ/AB Small Cap Growth Portfolio32,8800.05%US$228KJun 30, 2026
Schwab Total Stock Market Index Fund31,2790.05%US$183KJul 31, 2026
Small Cap Index Fund30,7350.05%US$213KJun 30, 2026
Global X Russell 2000 ETF28,3800.04%US$166KJul 31, 2026
T. Rowe Price Extended Equity Market Index Fund27,5000.04%US$191KJun 30, 2026
Vanguard Balanced Index Fund26,5520.04%US$184KJun 30, 2026
Ultra-Small Company Market Fund25,0000.04%US$174KJun 30, 2026
Fidelity ZERO Extended Market Index Fund24,3740.04%US$142KJul 31, 2026
Small Cap Index Fund22,6710.03%US$149KMay 31, 2026
Nuveen Equity Index Fund22,1530.03%US$129KJul 31, 2026
Vanguard Institutional Total Stock Market Index Fund21,3340.03%US$148KJun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio20,1000.03%US$139KJun 30, 2026
MetLife Russell 2000 Index Portfolio19,8900.03%US$138KJun 30, 2026
Small-Cap Index Portfolio18,4290.03%US$128KJun 30, 2026
AQR Small Cap Multi-Style Fund18,3140.03%US$127KJun 30, 2026
ATM Small Cap Managed Volatility Portfolio16,5850.03%US$115KJun 30, 2026
1290 VT Micro Cap Portfolio13,2870.02%US$92,212Jun 30, 2026
NVIT Small Cap Index Fund13,0240.02%US$90,387Jun 30, 2026

This page holds 50 of 108 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Moatazedi David
Director, Officer: See Remarks
Sale105,108USD 9.04US$950KSep 2, 2026

Big stakes

StakeStakeSharesDateFiling
Timothy P. Lynch9.90%6.43MDec 31, 2025Schedule 13G
Nantahala Capital Management, LLC8.85%5.73MSep 30, 2025Schedule 13G
Soleus Capital Master Fund, L.P.7.70%5.09MSep 30, 2026Schedule 13G
BlackRock, Inc.6.90%4.36MDec 31, 2024Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Gill
Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since Apr 2, 2026); Y mAbs Therapeutics (Director · Since at least Sep 20, 2018); Strongbridge Biopharma plc (Director · Sep 3, 2019 – Oct 5, 2021 · Past); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Nov 22, 2019 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past)
Director · Since at least Feb 12, 2018
Bosun Hau
Other companies: Exicure, Inc. (Director · Aug 2, 2019 – Jun 2, 2021 · Past); Bicycle Therapeutics PLC (Director · May 22, 2019 – May 22, 2019 · Past); Cellular Biomedicine Group Inc (Director · Feb 6, 2018 – May 18, 2018 · Past)
Director · Feb 7, 2018 – Jan 23, 2020 · Past
Peter C Farrell
Other companies: Arcturus Therapeutics Holdings Inc. (Director · Since at least Jan 1, 2019); ResMed Inc. (Director · Since at least Apr 2, 2007); NuVasive Inc (Director · May 24, 2007 – May 3, 2018 · Past)
Director · Jul 15, 2019 – Jan 27, 2023 · Past
David Moatazedi
Other companies: Biomerica, Inc. (President and Chief Executive Officer · Since at least Dec 7, 2022); Vyome Holdings, Inc. (Director · Mar 13, 2017 – Jul 23, 2019 · Past)
President and Chief Executive Officer · Since at least May 6, 2018
Karah Parschauer
Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Oct 18, 2024); Ultragenyx Pharmaceutical Inc. (EVP and Chief Legal Officer · Since at least Mar 1, 2024)
Director · Since at least Jan 30, 2024
Albert G White III
Other companies: The Cooper Companies, Inc. (President & CEO, Director · Since at least Apr 10, 2006)
Director · Since at least Jul 1, 2024
Crystal Muilenburg
Other companies: PMGC Holdings Inc. (Director · Nov 13, 2023 – Nov 13, 2023 · Past)
Chief Marketing Officer · Feb 25, 2021 – Mar 8, 2022 · Past
Michael M Jafar
Other companies: Desktop Metal Inc (CEO, DESKTOP HEALTH · Aug 11, 2021 – Jun 1, 2022 · Past)
See Remarks · Oct 28, 2020 – Jan 27, 2021 · Past
Murthy V Simhambhatla
Other companies: Abbott Laboratories (Senior Vice President · Jan 1, 2013 – Feb 27, 2015 · Past)
See Remarks, Director · Feb 7, 2018 – Feb 7, 2018 · Past
Rui Avelar
Other companies: Angiotech Pharmaceuticals Inc (Chief Medical Officer · Mar 31, 2008 – Mar 8, 2010 · Past)
Chief Medical Officer and Head of Research and Development · Since at least Feb 7, 2018
All 30 people
PersonSeat
Sandra Beaver
Other companies: Tandem Diabetes Care, Inc. (Director · Since at least Nov 7, 2025)
Chief Financial Officer · Sep 5, 2022 – May 13, 2025 · Past
Vikram Malik
Other companies: AEON Biopharma, Inc. (President, Director · Feb 8, 2021 – Feb 8, 2021 · Past)
Director · Since at least Feb 7, 2018
Brady StewartDirector · Since at least Feb 7, 2024
Donna Lynne ColonnaDirector of Medical Affairs, RN, BSN, Certified Nurse Injector, Certified Plastic Surgery Nurse · Since at least Nov 5, 2026
J Christopher MarmoChief Operating Officer · Feb 7, 2018 – Feb 7, 2018 · Past
Jeff PlumerGeneral Counsel · Since at least Nov 4, 2026
Jessica NovakChief People Officer · Since at least Nov 4, 2026
Jon YerburySenior Vice President, Operations · Since at least Nov 4, 2026
Kourtney CavallioSenior Vice President, Marketing · Since at least Nov 5, 2026
Kristine RomineDirector · Feb 7, 2018 – Jan 23, 2020 · Past
Kurt KnabSenior Vice President, Sales · Since at least Nov 4, 2026
Meha PatelDirector of Medical Affairs, PA-C, MSPAS · Since at least Nov 5, 2026
Monica ChampaneriaEvolus Medical Affairs Operations & Event Manager · Since at least Nov 5, 2026
Nareg SagherianVice President, Head of Global Investor Relations and Corporate Communications · Since at least Oct 1, 2026
Peter KreymermanEvolus VP & Head of Global Medical Affairs, Assistant Professor of Plastic Surgery at Campbell University · Since at least Nov 5, 2026
Robert HaymanDirector · Feb 5, 2021 – Feb 7, 2024 · Past
Simone BlankDirector · May 20, 2019 – Mar 7, 2025 · Past
Tatjana MitchellChief Financial Officer · Since at least Sep 8, 2025
Tomoko Yamagishi-DresslerChief Marketing Officer · Since at least Feb 7, 2024
Umberto La MagnaSenior Vice President, Evolus International · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Evolus, Inc. Common Stock.